P Amami1, I Dekker2, S Piacentini1, F Ferré1, L M Romito1, A Franzini3, E M J Foncke2, A Albanese4. 1. Neurologia I, Fondazione Istituto Neurologico Carlo Besta, Milano, Italy. 2. Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands. 3. Neurochirurgia III, Fondazione Istituto Neurologico Carlo Besta, Milano, Italy. 4. Neurologia I, Fondazione Istituto Neurologico Carlo Besta, Milano, Italy Istituto di Neurologia, Università Cattolica del Sacro Cuore, Milano, Italy.
Abstract
OBJECTIVE: To document the occurrence of impulse control behaviours (ICBs) in patients with Parkinson's disease after 3 years of continuous deep brain stimulation (DBS) of the subthalamic nucleus (STN). METHODS: Detailed neurological and ICB assessments were performed before STN DBS and up to 3 years after implant. RESULTS: 13 out of 56 patients (23.2%) had ICBs at baseline; they took higher doses of dopamine agonists (DAA). Three years after implant 11 had fully remitted with a 60.8% reduction of DAA medication; the remaining two, who had a similar medication reduction, had only compulsive eating, having recovered from hypersexuality. Six of the 43 patients without ICBs at baseline (14%) developed transient de novo ICBs after implant; none of them had ICBs at the 3-year observation. CONCLUSIONS: ICBs were abolished in patients 3 years after STN DBS and DAA dosages were lowered. New ICBs may occur after implant and are transient in most cases. Compulsive eating may be specifically related to STN stimulation. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
OBJECTIVE: To document the occurrence of impulse control behaviours (ICBs) in patients with Parkinson's disease after 3 years of continuous deep brain stimulation (DBS) of the subthalamic nucleus (STN). METHODS: Detailed neurological and ICB assessments were performed before STN DBS and up to 3 years after implant. RESULTS: 13 out of 56 patients (23.2%) had ICBs at baseline; they took higher doses of dopamine agonists (DAA). Three years after implant 11 had fully remitted with a 60.8% reduction of DAA medication; the remaining two, who had a similar medication reduction, had only compulsive eating, having recovered from hypersexuality. Six of the 43 patients without ICBs at baseline (14%) developed transient de novo ICBs after implant; none of them had ICBs at the 3-year observation. CONCLUSIONS:ICBs were abolished in patients 3 years after STN DBS and DAA dosages were lowered. New ICBs may occur after implant and are transient in most cases. Compulsive eating may be specifically related to STN stimulation. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Entities:
Keywords:
Behavioural Disorder; Parkinson's Disease; Surgery
Authors: Roberta Balestrino; Damiano Baroncini; Mario Fichera; Carmine Antonio Donofrio; Alberto Franzin; Pietro Mortini; Giancarlo Comi; Maria Antonietta Volontè Journal: Neurol Sci Date: 2017-09-14 Impact factor: 3.307
Authors: P Justin Rossi; Sol De Jesus; Christopher W Hess; Daniel Martinez-Ramirez; Kelly D Foote; Aysegul Gunduz; Michael S Okun Journal: Parkinsonism Relat Disord Date: 2017-08-09 Impact factor: 4.891
Authors: Adam Nassery; Christina A Palmese; Harini Sarva; Mark Groves; Joan Miravite; Brian Harris Kopell Journal: Curr Neurol Neurosci Rep Date: 2016-10 Impact factor: 5.081
Authors: Aristide Merola; Alberto Romagnolo; Laura Rizzi; Mario Giorgio Rizzone; Maurizio Zibetti; Michele Lanotte; George Mandybur; Andrew P Duker; Alberto J Espay; Leonardo Lopiano Journal: J Neurol Date: 2016-10-19 Impact factor: 4.849
Authors: D Val-Laillet; E Aarts; B Weber; M Ferrari; V Quaresima; L E Stoeckel; M Alonso-Alonso; M Audette; C H Malbert; E Stice Journal: Neuroimage Clin Date: 2015-03-24 Impact factor: 4.881